Researchers have generated six Zika virus antibodies that could be used to test for and possibly treat a mosquito-borne disease that has infected more than 1.5 million people worldwide. The antibodies “may have the dual utility as diagnostics capable of recognizing Zika virus subtypes and may be further developed to treat Zika virus infection,” corresponding […]Continue Reading ...
An interview with Eugenia Kuteeva conducted at SfN 2018, by Alina Shrourou, BSc. How can Neuroscience markers be used to advance our understanding of the brain? Neuroscience markers are monoclonal antibodies, developed for identification of the main anatomical and histochemical cell types in the central nervous system. They can therefore be used as markers of […]Continue Reading ...
Scientists investigating how the human immune system defends against malaria have uncovered a rare phenomenon: antibodies working together to bind to a vulnerable spot on the parasite. The new research, published recently in Science Advances, shows that antibodies working together can result in a protein on the parasite’s cell surface locking it into a spiral […]Continue Reading ...
The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody (nAb) therapies for the treatment of sepsis. Sepsis and septic shock are among the leading causes of death in intensive care units (ICUs). The global incidence of sepsis […]Continue Reading ...
IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced a collaborative paper published in Nature Communications with the Technical University of Denmark, and the Instituto Clodomiro Picado of the University of Costa Rica describing the development of a panel of human antibodies that neutralise elements of black mamba […]Continue Reading ...
Aug 24 2018 Two types of human antibodies that target different parts of the Ebola virus synergize their antiviral effects by inhibiting different steps of infection, according to a study published August 23 in the open-access journal PLOS Pathogens by Philipp Ilinykh and colleagues from the University of Texas Medical Branch, Vanderbilt University, and Ragon […]Continue Reading ...
August 9, 2018 A team at Scripps Research has come up with a faster way to analyze the outcome of experimental vaccines against HIV and other pathogens. Their new system lets scientists quickly assess the full spectrum of antibodies produced in an individual in response to a pathogen or vaccine and determine if these antibodies […]Continue Reading ...
July 31, 2018 Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans. Reporting July 17 in the journal Immunity, they describe the isolation of two potent monoclonal antibodies from human survivors of […]Continue Reading ...
Marina Caskey, a researcher who is part of a new clinical trial that shows that broadly neutralizing antibodies can suppress HIV for up to four months, far longer than currently available drugs. Credit: Mario Morgado/The Rockefeller University Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do […]Continue Reading ...
Levels of antiphospholipid antibodies, which are associated with rheumatic diseases, are also elevated in myocardial infarction without any autoimmune co-morbidity, a study from Karolinska Institutet in Sweden published in The Annals of Internal Medicine reports. Antiphospholipid antibodies (aPL) are a group of antibodies that target endogenous tissue, including the fat molecule cardiolipin and the plasma […]Continue Reading ...
An antibody (dark grey) is binding to an HIV envelope protein (coloured) on the surface of the virus (light grey). Credit: University of Zurich Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. […]Continue Reading ...
A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection. The research group of Prof Florian Klein, Director of the Institute of Virology at the University Hospital Cologne and scientist at the German Center for Infection Research (DZIF), has collaborated with scientists at the Rockefeller University in New York and […]Continue Reading ...
August 10, 2018 A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell. Their findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements. “This study presents results from an […]Continue Reading ...
July 30, 2018 Beckman Coulter Life Sciences now offers its largest portfolio of single color CE-IVD and ASR (analyte-specific reagent) conjugated antibodies. With the recent launch of two Kappa and two Lambda polyclonal antibodies, the company has introduced more than 30 additional CE-IVD reagents and 10 new ASRs in the last year. The entire portfolio […]Continue Reading ...
July 20, 2018 Scientists at the Mainz University Medical Center and the Max Planck Institute for Polymer Research (MPI-P) have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to […]Continue Reading ...
- Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Dry Age-Related Macular Degeneration with Geographic Atrophy
- Studies reveal role of red meat in gut bacteria, heart disease development
- Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin
- Researchers use brain connectome to reassess neuroimaging findings of Alzheimer’s disease
- “Miracle” baby survives Ebola in Congo and rapid a new Ebola detection device
- Study finds misuse of benzodiazepines to be highest among young adults
- TGen receives PayPal grant to underwrite costs of genetic tests for children with rare disorders
- New research highlights why HIV-infected patients suffer higher rates of cancer
- Antibiotic-resistant bacteria could soon be targeted with Alzheimer’s drug
- Rutgers scientists take an important step in making diseased hearts heal themselves
- Tailored Feedback at CRC Screen Improves Lifestyle Behaviors
- Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment
- How the Mediterranean Diet Can Help Women’s Hearts
- Sustained connections associated with symptoms of autism
- Concussion rates among young football players were higher than previously reported
- Cresco Labs granted approval to operate marijuana dispensary in Ohio
- Study provides insight into health risks facing new mothers
- AMSBIO expands Wnt signaling pathway product range to aid research
- Surgical treatment unnecessary for many prostate cancer patients
- Excess weight responsible for cancers globally finds report